NUS Links:
The drug Selinexor blocks specific protein that has been shown to be overexpressed in many types of cancer. Authors in this study evaluated the tolerability and the safety of this drug in Asian patients with advanced cancer and metastatic malignancies. Findings identified the recommended dose that can be used for future Selinexor monotherapy and drug combination studies for Asian patients.
Read more: https://journals.sagepub.com/doi/full/10.1177/17588359221087555
Gastric cancer (GC) has significant global mortality with high heterogeneity. A study of 226 GC samples from 121 patients integrated …
The tumour microenvironment (TME) plays a pivotal role in cancer progression, metastasis, and therapeutic resistance. Comprised of diverse cells, extracellular …
Research led by N2CR member Dr. Cheok Chit Fang found that the tumour suppressor protein p53 protects DNA during replication …